VRN04 / Voronoi - LARVOL DELTA

Voronoi Signs Technology Transfer Option Agreement with US Biotech Anbia [Google translation] (Medical News) - "Voronoi recently announced that it has signed a technology transfer option agreement with Anbia Therapeutics of the United States, granting it an exclusive option to acquire its pipeline VRN04....Under the agreement, Voronoi will receive 2.5 million shares of Anvia’s common stock as an upfront payment, and Anvia will provide additional funding necessary to develop the VRN04 final candidate."

Licensing / partnership • Immunology